Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60)

Leukemia

Volumn 11, Issue 4, 1997, Pages 504-513

  Freemerman, A J ^a   Vrana, J A ^a   Tombes, R M ^a   Jiang, H ^a   Chellappan, S P ^a   Fisher, P B ^a   Grant, S ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

Apoptosis; Ara C; Cell cycle arrest; HL 60 cells; MDA 6; p21

Indexed keywords

CD11B ANTIGEN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYTARABINE; CYTOTOXIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; COLONY FORMING UNIT; CONTROLLED STUDY; DNA TRANSFECTION; DRUG CYTOTOXICITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030941675     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400625     Document Type: Article

References (13)

1. Jiang H, Fisher PB. Use of a sensitive and efficent subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Differ 1993; 1: 285-299.
2. Jiang H, Lin J, Fisher PB. A molecular definition of terminal cell differentiation in human melanoma cells. Mol Cell Differ 1994; 2: 221-239.
3. Jiang H, Lin J, Su Z-Z, Kerbel RS, Herlyn M, Weissman RB, Welch D, Fisher PB. The melanoma differentiation associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation, and progression in human melanoma cells. Oncogene 1995; 10: 1855-1864.
4. Jiang H, Lin J, Su Z-Z, Fisher PB. The melanoma differentiation associated gene-6 (mda-6), which encodes the cyclin-dependent kinase inhibitor p21, may function as a negative regulator of human melanoma growth and progression. Mol Cell Differ 1996; 4: 67-89.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
6. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Nature 1993; 366: 701-704.
7. 1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
8. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
9. Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994; 9: 2261-2268.
10. Sheikh MS, Li X-S, Chen J-C, Shao Z-M, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994; 9: 3407-3415.
11. Steinman RA, Huffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 1994; 9: 3389-3396.
12. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-8497.
13. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8: 1750-1758.